Please login to the form below

Not currently logged in
Email:
Password:

epilepsy

This page shows the latest epilepsy news and features for those working in and with pharma, biotech and healthcare.

Sanofi faces manslaughter allegations in France over Depakine deaths

Sanofi faces manslaughter allegations in France over Depakine deaths

Sanofi is being investigated for manslaughter charges in France relating to side-effects caused by the company’s anti-epilepsy drug Depakine (valproate). ... This means that women treated with Depakine for epilepsy were up to four times likelier to

Latest news

  • US piles pressure on Mallinckrodt over alleged Acthar fraud US piles pressure on Mallinckrodt over alleged Acthar fraud

    thanks to new indications, including a 2010 approval – under a New Drug Application – for the treatment of infantile spasms, an extremely rare, potentially fatal form of epilepsy.

  • Sanofi indicted in France over epilepsy drug birth defects Sanofi indicted in France over epilepsy drug birth defects

    Sanofi has revealed that it has been indicted in France in connection with an investigation over birth defects linked to one of its epilepsy drugs. ... Despite its maturity, the drug has been one of Sanofi’s reliable mid-size products, bringing in

  • Congenica launches new application Congenica Neuro Congenica launches new application Congenica Neuro

    Provides faster analysis of epilepsy and neurodevelopmental disorders. Digital health company Congenica has launched a new application on its clinical decision support programme named Congenica Neuro. . ... Around 300 million people around the world

  • Pfizer, Flynn face reinstatement of £90m CMA fine Pfizer, Flynn face reinstatement of £90m CMA fine

    Facing penalty for dramatic price hikes of an epilepsy drug. The UK’s competition regulator is pushing to reinstate a £90m fine for Pfizer and Flynn Pharma – quashed last year – over ... to treat epilepsy for decades, which at the time was

  • FDA clears SK Life Science’s anti-epileptic drug Xcopri FDA clears SK Life Science’s anti-epileptic drug Xcopri

    The safety profile of the anti-epilepsy drug does include side effects – Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) was reported among patients taking Xcopri. ... New medications for epilepsy are pivotal, as seizures can cause

More from news
Approximately 32 fully matching, plus 181 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 12 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...

Infographics